---
title: "Firefly Neuroscience Raises $8 Million; Investors Agree to 30-Day Lock-Up After Offering"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283720940.md"
description: "Firefly Neuroscience has raised $8 million through a private placement, issuing 5,333,333 Units at $1.50 each to an accredited investor. Investors have agreed to a 30-day lock-up period until May 16, 2026, to support orderly trading post-financing. The offering was conducted under Regulation D, and the deadline for filing a resale registration statement has been extended to May 21, 2026. This financing aims to enhance liquidity and fund operations."
datetime: "2026-04-22T20:33:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283720940.md)
  - [en](https://longbridge.com/en/news/283720940.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283720940.md)
---

# Firefly Neuroscience Raises $8 Million; Investors Agree to 30-Day Lock-Up After Offering

Firefly Neuroscience completed an $8.0 million additional private placement on April 16, 2026, issuing 5,333,333 Units at $1.50 per Unit to an accredited investor under its existing Securities Purchase Agreement. In connection with the closing, investors agreed to a 30-day lock-up on certain securities through May 16, 2026, after which restrictions fully lapse. The offering was conducted under Section 4(a)(2) and Rule 506(b) of Regulation D, and investors extended the deadline for the company to file the related resale registration statement to May 21, 2026. The transactions are expected to provide added liquidity and promote an orderly market post-financing.

**Agreement 1: Firefly Neuroscience Raises $8 Million in Additional Private Placement at $1.50 Per Unit**

-   **Agreement type**: Additional Closing under Securities Purchase Agreement (private placement of Units)
-   **Counterparty**: an accredited investor
-   **Signed / Effective**: Apr 16 2026 / same
-   **Duration / Termination**: At will
-   **Reason**: Strengthen liquidity and fund operations

**Agreement 2: Firefly Neuroscience Implements 30-Day Lock-Up With Investors After Equity Financing**

-   **Agreement type**: Amended and Restated Lock-Up Agreement
-   **Counterparty**: Investors
-   **Signed / Effective**: Apr 16 2026 / same
-   **Duration / Termination**: 30 days, ending May 16 2026
-   **Reason**: Support orderly trading following the financing

Original SEC Filing: FIREFLY NEUROSCIENCE, INC. \[ AIFF \] - 8-K - Apr. 22, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [AIFF.US](https://longbridge.com/en/quote/AIFF.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)

## Related News & Research

- [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md)
- [Lantern Pharma raises capital, plans AI platform spinoff](https://longbridge.com/en/news/286480334.md)
- [Wave Life Sciences posts positive RestorAATion-2 data; WVE-006 restores M-AAT, cuts Z-AAT, supports monthly dosing](https://longbridge.com/en/news/286818220.md)
- [Eton Pharmaceuticals Q1 product sales rise driven by portfolio expansion](https://longbridge.com/en/news/286461579.md)
- [Legend Biotech Q1 Solid for Carvykti, Focus Shifts to In Vivo Pipeline, RBC Says](https://longbridge.com/en/news/286290495.md)